Synapse

← Clinical & Translational Immunology

Papers in Clinical & Translational Immunology

Page 4 · newest first

  1. Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritisClinical & Translational Immunology · 2023
  2. The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiationClinical & Translational Immunology · 2023
  3. The interaction between Epstein–Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunitiesClinical & Translational Immunology · 2023
  4. A case of T‐cell‐Epstein–Barr virus‐haemophagocytic lymphohistiocytosis and sustained remission following ruxolitinib therapyClinical & Translational Immunology · 2023
  5. Improving thymus implantation for congenital athymia with interleukin‐7Clinical & Translational Immunology · 2023
  6. Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastomaClinical & Translational Immunology · 2023
  7. Glucocorticoid regulation of the mTORC1 pathway modulates CD4⁺ T cell responses during infectionClinical & Translational Immunology · 2023
  8. Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumorsClinical & Translational Immunology · 2023
  9. CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative diseaseClinical & Translational Immunology · 2023
  10. JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid‐derived suppressor cells via the JAK/STAT and ROS‐MAPK/NF‐κB signalling pathways in acute graft‐versus‐host diseaseClinical & Translational Immunology · 2023
  11. Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?Clinical & Translational Immunology · 2023
  12. Antibody glycosylation correlates with disease progression in SIV‐Mycobacterium tuberculosis coinfected cynomolgus macaquesClinical & Translational Immunology · 2023
  13. Autoimmune uveitis in Behçet's disease and Vogt‐Koyanagi‐Harada disease differ in tissue immune infiltration and T cell clonalityClinical & Translational Immunology · 2023
  14. Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinomaClinical & Translational Immunology · 2023
  15. Elevated BMI reduces the humoral response to SARS‐CoV‐2 infectionClinical & Translational Immunology · 2023
  16. Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanismClinical & Translational Immunology · 2023
  17. Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severityClinical & Translational Immunology · 2023
  18. Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunityClinical & Translational Immunology · 2023
  19. Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritisClinical & Translational Immunology · 2023
  20. Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantationClinical & Translational Immunology · 2023
  21. From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosisClinical & Translational Immunology · 2023
  22. Inflammatory cytokines as mediators of retinal endothelial barrier dysfunction in non‐infectious uveitisClinical & Translational Immunology · 2023
  23. Circulating CXCR5⁺ natural killer cells are expanded in patients with myasthenia gravisClinical & Translational Immunology · 2023
  24. The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related diseaseClinical & Translational Immunology · 2023
  25. Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunityClinical & Translational Immunology · 2023
  26. Roadmap for understanding mechanisms on how Epstein–Barr virus triggers multiple sclerosis and for translating these discoveries in clinical trialsClinical & Translational Immunology · 2023
  27. Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanomaClinical & Translational Immunology · 2023
  28. Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remissionClinical & Translational Immunology · 2023
  29. Design, optimisation and standardisation of a high‐dimensional spectral flow cytometry workflow assessing T‐cell immunophenotype in patients with melanomaClinical & Translational Immunology · 2023
  30. Assessment of antibodies in the upper and lower human respiratory tract at steady state and after respiratory viral infectionClinical & Translational Immunology · 2023
  31. Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitionsClinical & Translational Immunology · 2023
  32. The prometastatic relevance of tumor‐infiltrating B lymphocytes in laryngeal squamous cell carcinomaClinical & Translational Immunology · 2023
  33. Allogeneic haematopoietic cell transplants as dynamical systems: influence of early‐term immune milieu on long‐term T‐cell recoveryClinical & Translational Immunology · 2023
  34. Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infectionClinical & Translational Immunology · 2023
  35. Mass cytometry analysis reveals altered immune profiles in patients with coronary artery diseaseClinical & Translational Immunology · 2023
  36. Enhanced and complementary benefits of a nalfurafine and fingolimod combination to treat immune‐driven demyelinationClinical & Translational Immunology · 2023
  37. Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinomaClinical & Translational Immunology · 2023
  38. Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polypsClinical & Translational Immunology · 2023
  39. Epstein–Barr virus and multiple sclerosis: the dawn of a new ageClinical & Translational Immunology · 2023
  40. Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myelomaClinical & Translational Immunology · 2023
  41. A specific anti‐COVID‐19 BNT162b2 vaccine‐induced early innate immune signature positively correlates with the humoral protective response in healthy and multiple sclerosis vaccine recipientsClinical & Translational Immunology · 2023
  42. A unique cytotoxic CD4 + T cell‐signature defines critical COVID‐19Clinical & Translational Immunology · 2023
  43. Released dsDNA‐triggered inflammasomes serve as intestinal radioprotective targetsClinical & Translational Immunology · 2023
  44. Understanding the tumor microenvironment in head and neck squamous cell carcinomaClinical & Translational Immunology · 2022
  45. Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma modelsClinical & Translational Immunology · 2022
  46. A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccinationClinical & Translational Immunology · 2022
  47. Modelling the tumor immune microenvironment for precision immunotherapyClinical & Translational Immunology · 2022
  48. Circulating CD8 ⁺ mucosal‐associated invariant T cells correlate with improved treatment responses and overall survival in anti‐PD‐1‐treated melanoma patientsClinical & Translational Immunology · 2022
  49. Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitroClinical & Translational Immunology · 2022
  50. Epigenetic regulation of inflammation by microRNAs in post‐infectious bronchiolitis obliteransClinical & Translational Immunology · 2022